Margatoxin
Alternative Names: MgTXLatest Information Update: 25 Sep 2021
At a glance
- Originator Merck & Co
- Class Venoms
- Mechanism of Action Immunosuppressants; Lymphocyte inhibitors; Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders; Transplant rejection
Most Recent Events
- 26 Jul 2001 No-Development-Reported for Autoimmune disorders in USA (Unknown route)
- 26 Jul 2001 No-Development-Reported for Transplant rejection in USA (Unknown route)
- 27 May 1997 New profile